Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Frame

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2024
Acceleration of infectious disease drug discovery and development using a humanized model of drug metabolismA Kenneth MacLeod, Kevin-Sebastien Coquelin, Leticia Huertas, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 14, 2026
Hedera helix-derived α-hederin (IVL-11) demonstrates both ex vivo and in vivo flukicidal activities against Fasciola hepaticaSarah D Davey, Anand Chakroborty, Joseph Payne, et al.
Science Translational Medicine|July 9, 2025
Antitrypanosomal quinazolines targeting lysyl-tRNA synthetase show partial efficacy in a mouse model of acute Chagas diseaseLindsay B Tulloch, Hugh Tawell, Annie E Taylor, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2026
Use of a cytochrome P450 humanized mouse model to refine schistosomiasis drug discoverySarah D Davey, Josephine E Forde-Thomas, Benjamin J Hulme, et al.
Science Translational Medicine|October 23, 2024
<i>Cryptosporidium</i> lysyl-tRNA synthetase inhibitors define the interplay between solubility and permeability required to achieve efficacyNicola Caldwell, Caroline Peet, Peter Miller, et al.
Journal of Medicinal Chemistry|July 28, 2023
Structure-Guided Design and Synthesis of a Pyridazinone Series of <i>Trypanosoma cruzi</i> Proteasome InhibitorsMichael G Thomas, Kate McGonagle, Paul Rowland, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2024
Acceleration of infectious disease drug discovery and development using a humanized model of drug metabolismA Kenneth MacLeod, Kevin-Sebastien Coquelin, Leticia Huertas, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 14, 2026
Hedera helix-derived α-hederin (IVL-11) demonstrates both ex vivo and in vivo flukicidal activities against Fasciola hepaticaSarah D Davey, Anand Chakroborty, Joseph Payne, et al.
Science Translational Medicine|July 9, 2025
Antitrypanosomal quinazolines targeting lysyl-tRNA synthetase show partial efficacy in a mouse model of acute Chagas diseaseLindsay B Tulloch, Hugh Tawell, Annie E Taylor, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2026
Use of a cytochrome P450 humanized mouse model to refine schistosomiasis drug discoverySarah D Davey, Josephine E Forde-Thomas, Benjamin J Hulme, et al.
Science Translational Medicine|October 23, 2024
<i>Cryptosporidium</i> lysyl-tRNA synthetase inhibitors define the interplay between solubility and permeability required to achieve efficacyNicola Caldwell, Caroline Peet, Peter Miller, et al.
Journal of Medicinal Chemistry|July 28, 2023
Structure-Guided Design and Synthesis of a Pyridazinone Series of <i>Trypanosoma cruzi</i> Proteasome InhibitorsMichael G Thomas, Kate McGonagle, Paul Rowland, et al.
Pageof 2